1 Study Coverage 1.1 Vaccines For Children (VFC) Product Introduction 1.2 Market by Type 1.2.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Type 1.2.2 Recombinant Vaccines 1.2.3 Viral Vaccines 1.2.4 Polysaccharide Vaccines 1.2.5 Others 1.3 Market by Application 1.3.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Application 1.3.2 Government Institution 1.3.3 Private Sector 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Vaccines For Children (VFC) Market Size, Estimates and Forecasts 2.1.1 Global Vaccines For Children (VFC) Revenue 2016-2027 2.1.2 Global Vaccines For Children (VFC) Sales 2016-2027 2.2 Global Vaccines For Children (VFC), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Vaccines For Children (VFC) Historical Market Size by Region (2016-2021) 2.3.1 Global Vaccines For Children (VFC) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Vaccines For Children (VFC) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Vaccines For Children (VFC) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Vaccines For Children (VFC) Sales Forecast by Region (2022-2027) 2.4.2 Global Vaccines For Children (VFC) Revenue Forecast by Region (2022-2027) 3 Global Vaccines For Children (VFC) Competitor Landscape by Players 3.1 Global Top Vaccines For Children (VFC) Manufacturers by Sales 3.1.1 Global Vaccines For Children (VFC) Sales by Manufacturer (2016-2021) 3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Vaccines For Children (VFC) Manufacturers by Revenue 3.2.1 Key Vaccines For Children (VFC) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Vaccines For Children (VFC) Revenue by Manufacturers (2016-2021) 3.2.3 Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Vaccines For Children (VFC) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Vaccines For Children (VFC) Revenue in 2020 3.2.6 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Vaccines For Children (VFC) Price by Manufacturers 3.4 Global Vaccines For Children (VFC) Manufacturing Base Distribution, Product Types 3.4.1 Vaccines For Children (VFC) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Vaccines For Children (VFC) Product Type 3.4.3 Date of International Manufacturers Enter into Vaccines For Children (VFC) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Vaccines For Children (VFC) Market Size by Type (2016-2021) 4.1.1 Global Vaccines For Children (VFC) Sales by Type (2016-2021) 4.1.2 Global Vaccines For Children (VFC) Revenue by Type (2016-2021) 4.1.3 Vaccines For Children (VFC) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Vaccines For Children (VFC) Market Size Forecast by Type (2022-2027) 4.2.1 Global Vaccines For Children (VFC) Sales Forecast by Type (2022-2027) 4.2.2 Global Vaccines For Children (VFC) Revenue Forecast by Type (2022-2027) 4.2.3 Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Vaccines For Children (VFC) Market Size by Application (2016-2021) 5.1.1 Global Vaccines For Children (VFC) Sales by Application (2016-2021) 5.1.2 Global Vaccines For Children (VFC) Revenue by Application (2016-2021) 5.1.3 Vaccines For Children (VFC) Price by Application (2016-2021) 5.2 Vaccines For Children (VFC) Market Size Forecast by Application (2022-2027) 5.2.1 Global Vaccines For Children (VFC) Sales Forecast by Application (2022-2027) 5.2.2 Global Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027) 5.2.3 Global Vaccines For Children (VFC) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 6.1.1 Japan Vaccines For Children (VFC) Sales YoY Growth 2016-2027 6.1.2 Japan Vaccines For Children (VFC) Revenue YoY Growth 2016-2027 6.1.3 Japan Vaccines For Children (VFC) Market Share in Global Market 2016-2027 6.2 Japan Vaccines For Children (VFC) Market Size by Players (International and Local Players) 6.2.1 Japan Top Vaccines For Children (VFC) Players by Sales (2016-2021) 6.2.2 Japan Top Vaccines For Children (VFC) Players by Revenue (2016-2021) 6.3 Japan Vaccines For Children (VFC) Historic Market Review by Type (2016-2021) 6.3.1 Japan Vaccines For Children (VFC) Sales Market Share by Type (2016-2021) 6.3.2 Japan Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Vaccines For Children (VFC) Price by Type (2016-2021) 6.4 Japan Vaccines For Children (VFC) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Vaccines For Children (VFC) Sales Forecast by Type (2022-2027) 6.4.2 Japan Vaccines For Children (VFC) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Vaccines For Children (VFC) Price Forecast by Type (2022-2027) 6.5 Japan Vaccines For Children (VFC) Historic Market Review by Application (2016-2021) 6.5.1 Japan Vaccines For Children (VFC) Sales Market Share by Application (2016-2021) 6.5.2 Japan Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Vaccines For Children (VFC) Price by Application (2016-2021) 6.6 Japan Vaccines For Children (VFC) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Vaccines For Children (VFC) Sales Forecast by Application (2022-2027) 6.6.2 Japan Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Vaccines For Children (VFC) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 7.2 North America Vaccines For Children (VFC) Market Facts & Figures by Country 7.2.1 North America Vaccines For Children (VFC) Sales by Country (2016-2021) 7.2.2 North America Vaccines For Children (VFC) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Vaccines For Children (VFC) Market Facts & Figures by Region 8.2.1 Asia Pacific Vaccines For Children (VFC) Sales by Region (2016-2021) 8.2.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 9.2 Europe Vaccines For Children (VFC) Market Facts & Figures by Country 9.2.1 Europe Vaccines For Children (VFC) Sales by Country (2016-2021) 9.2.2 Europe Vaccines For Children (VFC) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 10.2 Latin America Vaccines For Children (VFC) Market Facts & Figures by Country 10.2.1 Latin America Vaccines For Children (VFC) Sales by Country (2016-2021) 10.2.2 Latin America Vaccines For Children (VFC) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Vaccines For Children (VFC) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Vaccines For Children (VFC) Market Facts & Figures by Country 11.2.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GSK 12.1.1 GSK Corporation Information 12.1.2 GSK Description and Business Overview 12.1.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GSK Vaccines For Children (VFC) Products Offered 12.1.5 GSK Recent Development 12.2 Sanofi 12.2.1 Sanofi Corporation Information 12.2.2 Sanofi Description and Business Overview 12.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sanofi Vaccines For Children (VFC) Products Offered 12.2.5 Sanofi Recent Development 12.3 Merck 12.3.1 Merck Corporation Information 12.3.2 Merck Description and Business Overview 12.3.3 Merck Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Merck Vaccines For Children (VFC) Products Offered 12.3.5 Merck Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Description and Business Overview 12.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Vaccines For Children (VFC) Products Offered 12.4.5 Pfizer Recent Development 12.5 Jintan 12.5.1 Jintan Corporation Information 12.5.2 Jintan Description and Business Overview 12.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Jintan Vaccines For Children (VFC) Products Offered 12.5.5 Jintan Recent Development 12.6 CSL 12.6.1 CSL Corporation Information 12.6.2 CSL Description and Business Overview 12.6.3 CSL Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 CSL Vaccines For Children (VFC) Products Offered 12.6.5 CSL Recent Development 12.7 MedImmune LLC 12.7.1 MedImmune LLC Corporation Information 12.7.2 MedImmune LLC Description and Business Overview 12.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 MedImmune LLC Vaccines For Children (VFC) Products Offered 12.7.5 MedImmune LLC Recent Development 12.8 J&J(Crucell) 12.8.1 J&J(Crucell) Corporation Information 12.8.2 J&J(Crucell) Description and Business Overview 12.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 J&J(Crucell) Vaccines For Children (VFC) Products Offered 12.8.5 J&J(Crucell) Recent Development 12.9 China National Biotec 12.9.1 China National Biotec Corporation Information 12.9.2 China National Biotec Description and Business Overview 12.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 China National Biotec Vaccines For Children (VFC) Products Offered 12.9.5 China National Biotec Recent Development 12.10 Tiantan 12.10.1 Tiantan Corporation Information 12.10.2 Tiantan Description and Business Overview 12.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Tiantan Vaccines For Children (VFC) Products Offered 12.10.5 Tiantan Recent Development 12.11 GSK 12.11.1 GSK Corporation Information 12.11.2 GSK Description and Business Overview 12.11.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GSK Vaccines For Children (VFC) Products Offered 12.11.5 GSK Recent Development 12.12 Kangtai 12.12.1 Kangtai Corporation Information 12.12.2 Kangtai Description and Business Overview 12.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Kangtai Products Offered 12.12.5 Kangtai Recent Development 12.13 Hissen 12.13.1 Hissen Corporation Information 12.13.2 Hissen Description and Business Overview 12.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Hissen Products Offered 12.13.5 Hissen Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Vaccines For Children (VFC) Industry Trends 13.2 Vaccines For Children (VFC) Market Drivers 13.3 Vaccines For Children (VFC) Market Challenges 13.4 Vaccines For Children (VFC) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Vaccines For Children (VFC) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Recombinant Vaccines Table 3. Major Manufacturers of Viral Vaccines Table 4. Major Manufacturers of Polysaccharide Vaccines Table 5. Major Manufacturers of Others Table 6. Global Vaccines For Children (VFC) Market Size Growth Rate by Application (2021-2027) & (K Doses) Table 7. Global Vaccines For Children (VFC) Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Vaccines For Children (VFC) Sales by Regions (2016-2021) & (K Doses) Table 9. Global Vaccines For Children (VFC) Sales Market Share by Regions (2016-2021) Table 10. Global Vaccines For Children (VFC) Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Vaccines For Children (VFC) Sales Forecast by Region (2022-2027) & (K Doses) Table 12. Global Vaccines For Children (VFC) Sales Market Share Forecast by Region (2022-2027) Table 13. Global Vaccines For Children (VFC) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Vaccines For Children (VFC) Sales by Manufacturers (2016-2021) (K Doses) Table 16. Global Vaccines For Children (VFC) Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Vaccines For Children (VFC) Manufacturers by Revenue (US$ Million) in 2020 Table 18. Vaccines For Children (VFC) Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Vaccines For Children (VFC) Revenue Share by Manufacturers (2016-2021) Table 20. Global Vaccines For Children (VFC) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Vaccines For Children (VFC) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines For Children (VFC) as of 2020) Table 22. Key Manufacturers Vaccines For Children (VFC) Price (2016-2021) (US$/Dose) Table 23. Vaccines For Children (VFC) Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Vaccines For Children (VFC) Product Type Table 25. Date of International Manufacturers Enter into Vaccines For Children (VFC) Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Vaccines For Children (VFC) Sales by Type (2016-2021) (K Doses) Table 28. Global Vaccines For Children (VFC) Sales Share by Type (2016-2021) Table 29. Global Vaccines For Children (VFC) Revenue by Type (2016-2021) (US$ Million) Table 30. Global Vaccines For Children (VFC) Revenue Share by Type (2016-2021) Table 31. Vaccines For Children (VFC) Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose) Table 32. Global Vaccines For Children (VFC) Sales Forecast by Type (2022-2027) & (K Doses) Table 33. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2022-2027) Table 34. Global Vaccines For Children (VFC) Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose) Table 37. Global Vaccines For Children (VFC) Sales by Application (2016-2021) (K Doses) Table 38. Global Vaccines For Children (VFC) Sales Share by Application (2016-2021) Table 39. Global Vaccines For Children (VFC) Revenue by Application (2016-2021) (US$ Million) Table 40. Global Vaccines For Children (VFC) Revenue Share by Application (2016-2021) Table 41. Vaccines For Children (VFC) Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose) Table 42. Global Vaccines For Children (VFC) Sales Forecast by Application (2022-2027) & (K Doses) Table 43. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2022-2027) Table 44. Global Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose) Table 47. Japan Vaccines For Children (VFC) Sales (K Doses) of Key Companies (2016-2021) Table 48. Japan Vaccines For Children (VFC) Sales Share by Company (2016-2021) Table 49. Japan Vaccines For Children (VFC) Revenue (US$ Million) by Company (2016-2021) Table 50. Japan Vaccines For Children (VFC) Revenue Share by Company (2016-2021) Table 51. Japan Vaccines For Children (VFC) Sales (K Doses) by Type (2016-2021) Table 52. Japan Vaccines For Children (VFC) Sales Share by Type (2016-2021) Table 53. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. Japan Vaccines For Children (VFC) Price (US$/Dose) by Type (2016-2021) Table 55. Japan Vaccines For Children (VFC) Sales (K Doses) by Type (2022-2027) Table 56. Japan Vaccines For Children (VFC) Sales Share by Type (2022-2027) Table 57. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. Japan Vaccines For Children (VFC) Revenue Share by Type (2022-2027) Table 59. Japan Vaccines For Children (VFC) Price (US$/Dose) by Type (2022-2027) Table 60. Japan Vaccines For Children (VFC) Sales (K Doses) by Application (2016-2021) Table 61. Japan Vaccines For Children (VFC) Sales Share by Application (2016-2021) Table 62. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. Japan Vaccines For Children (VFC) Price (US$/Dose) by Application (2016-2021) Table 64. Japan Vaccines For Children (VFC) Sales (K Doses) by Application (2022-2027) Table 65. Japan Vaccines For Children (VFC) Sales Share by Application (2022-2027) Table 66. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. Japan Vaccines For Children (VFC) Revenue Share by Application (2022-2027) Table 68. Japan Vaccines For Children (VFC) Price (US$/Dose) by Application (2022-2027) Table 69. North America Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses) Table 70. North America Vaccines For Children (VFC) Sales Market Share by Country (2016-2021) Table 71. North America Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Vaccines For Children (VFC) Sales by Region (2016-2021) & (K Doses) Table 74. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021) Table 77. Europe Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses) Table 78. Europe Vaccines For Children (VFC) Sales Market Share by Country (2016-2021) Table 79. Europe Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021) Table 81. Latin America Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses) Table 82. Latin America Vaccines For Children (VFC) Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses) Table 86. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021) Table 89. GSK Corporation Information Table 90. GSK Description and Business Overview Table 91. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 92. GSK Vaccines For Children (VFC) Product Table 93. GSK Recent Development Table 94. Sanofi Corporation Information Table 95. Sanofi Description and Business Overview Table 96. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 97. Sanofi Product Table 98. Sanofi Recent Development Table 99. Merck Corporation Information Table 100. Merck Description and Business Overview Table 101. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 102. Merck Product Table 103. Merck Recent Development Table 104. Pfizer Corporation Information Table 105. Pfizer Description and Business Overview Table 106. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 107. Pfizer Product Table 108. Pfizer Recent Development Table 109. Jintan Corporation Information Table 110. Jintan Description and Business Overview Table 111. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 112. Jintan Product Table 113. Jintan Recent Development Table 114. CSL Corporation Information Table 115. CSL Description and Business Overview Table 116. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 117. CSL Product Table 118. CSL Recent Development Table 119. MedImmune LLC Corporation Information Table 120. MedImmune LLC Description and Business Overview Table 121. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 122. MedImmune LLC Product Table 123. MedImmune LLC Recent Development Table 124. J&J(Crucell) Corporation Information Table 125. J&J(Crucell) Description and Business Overview Table 126. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 127. J&J(Crucell) Product Table 128. J&J(Crucell) Recent Development Table 129. China National Biotec Corporation Information Table 130. China National Biotec Description and Business Overview Table 131. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 132. China National Biotec Product Table 133. China National Biotec Recent Development Table 134. Tiantan Corporation Information Table 135. Tiantan Description and Business Overview Table 136. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 137. Tiantan Product Table 138. Tiantan Recent Development Table 139. Hualan Corporation Information Table 140. Hualan Description and Business Overview Table 141. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 142. Hualan Product Table 143. Hualan Recent Development Table 144. Kangtai Corporation Information Table 145. Kangtai Description and Business Overview Table 146. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 147. Kangtai Product Table 148. Kangtai Recent Development Table 149. Hissen Corporation Information Table 150. Hissen Description and Business Overview Table 151. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 152. Hissen Product Table 153. Hissen Recent Development Table 154. Vaccines For Children (VFC) Market Trends Table 155. Vaccines For Children (VFC) Market Drivers Table 156. Vaccines For Children (VFC) Market Challenges Table 157. Vaccines For Children (VFC) Market Restraints Table 158. Vaccines For Children (VFC) Customers List Table 159. Vaccines For Children (VFC) Distributors List Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Vaccines For Children (VFC) Product Picture Figure 2. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020 & 2027 Figure 3. Recombinant Vaccines Product Picture Figure 4. Viral Vaccines Product Picture Figure 5. Polysaccharide Vaccines Product Picture Figure 6. Others Product Picture Figure 7. Global Vaccines For Children (VFC) Sales Market Share by Application in 2020 & 2027 Figure 8. Government Institution Figure 9. Private Sector Figure 10. Other Figure 11. Vaccines For Children (VFC) Report Years Considered Figure 12. Global Vaccines For Children (VFC) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Vaccines For Children (VFC) Market Size 2016-2027 (US$ Million) Figure 14. Global Vaccines For Children (VFC) Sales 2016-2027 (K Doses) Figure 15. Global Vaccines For Children (VFC) Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Vaccines For Children (VFC) Sales Market Share by Region (2016-2021) Figure 17. Global Vaccines For Children (VFC) Sales Market Share by Region in 2020 Figure 18. Global Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021) Figure 19. Global Vaccines For Children (VFC) Revenue Market Share by Region in 2020 Figure 20. Global Vaccines For Children (VFC) Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Vaccines For Children (VFC) Revenue in 2020 Figure 22. Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2021) Figure 24. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020 Figure 25. Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021) Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Type in 2020 Figure 27. Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2021) Figure 28. Global Vaccines For Children (VFC) Sales Market Share by Application in 2020 Figure 29. Global Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021) Figure 30. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2020 Figure 31. Japan Vaccines For Children (VFC) Sales Growth Rate 2016-2027 (K Doses) Figure 32. Japan Vaccines For Children (VFC) Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. Japan Vaccines For Children (VFC) Market Share in Global Market 2016-2027 Figure 34. Japan 5 and 10 Largest Vaccines For Children (VFC) Players Market Share by Revenue in Vaccines For Children (VFC) in 2020 Figure 35. Japan Vaccines For Children (VFC) Revenue Share by Type (2016-2021) Figure 36. Japan Vaccines For Children (VFC) Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Japan Vaccines For Children (VFC) Revenue Share by Application (2016-2021) Figure 38. Japan Vaccines For Children (VFC) Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses) Figure 40. North America Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Vaccines For Children (VFC) Sales Market Share by Country in 2020 Figure 42. North America Vaccines For Children (VFC) Revenue Market Share by Country in 2020 Figure 43. U.S. Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 44. U.S. Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 46. Canada Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses) Figure 48. Europe Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2020 Figure 50. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2020 Figure 51. Germany Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 52. Germany Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 54. France Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 56. U.K. Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 58. Italy Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 60. Russia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses) Figure 62. Asia Pacific Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Region in 2020 Figure 64. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Region in 2020 Figure 65. China Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 66. China Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 68. Japan Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 70. South Korea Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 72. India Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 74. Australia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 76. Taiwan Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 78. Indonesia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 80. Thailand Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 82. Malaysia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 84. Philippines Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 86. Vietnam Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses) Figure 88. Latin America Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Vaccines For Children (VFC) Sales Market Share by Country in 2020 Figure 90. Latin America Vaccines For Children (VFC) Revenue Market Share by Country in 2020 Figure 91. Mexico Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 92. Mexico Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 94. Brazil Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 96. Argentina Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses) Figure 98. Middle East and Africa Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2020 Figure 101. Turkey Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 102. Turkey Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 104. Saudi Arabia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses) Figure 106. UAE Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Vaccines For Children (VFC) Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

GSK Sanofi Merck Pfizer Jintan CSL MedImmune LLC J&J(Crucell) China National Biotec Tiantan Hualan Kangtai Hissen